PUBLISHER: TechNavio | PRODUCT CODE: 1432226
PUBLISHER: TechNavio | PRODUCT CODE: 1432226
The continuous renal replacement therapy devices market is forecasted to grow by USD 611.31 mn during 2023-2028, accelerating at a CAGR of 8.07% during the forecast period. The report on the continuous renal replacement therapy devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advantages of CRRT over IRRT, increase in incidence of acute kidney injury (AKI) and associated risk factors, and rapid increase in aging population.
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 6.99% |
CAGR | 8.07% |
Incremental Value | $611.31mn |
Technavio's continuous renal replacement therapy devices market is segmented as below:
By Product
By End-user
By Geographical Landscape
This study identifies the opportunities in emerging markets as one of the prime reasons driving the continuous renal replacement therapy devices market growth during the next few years. Also, focus on miniaturization and wearable technology and for infant and pediatric applications and technological advances in CRRT will lead to sizable demand in the market.
The report on the continuous renal replacement therapy devices market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading continuous renal replacement therapy devices market vendors that include Ardia Digital Health Ltd., Astellas Pharma Inc., B.Braun SE, Baxter International Inc., CytoSorbents Corp., DaVita Inc., DIAMED Medizintechnik GmbH, ECRI, Fresenius Medical Care AG and Co. KGaA, Infomed SA, Medica S.p.A., Medical Components Inc., Medtronic Plc, Nikkiso Co. Ltd., Nipro Medical Corp., SWS Hemodialysis Care Co. Ltd., Toray Industries Inc., Apollo Health and Lifestyle Ltd., Asahi Kasei Corp., and Medites Pharma spol. s.r.o.. Also, the continuous renal replacement therapy devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: